Rockwell Medical (RMTI) Revenue Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 2.94% |
| 10 | Rockwell Medical | 28.46 Mn | 4.57 Mn | 2.90 Mn | -4.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.12% |
| Dec 31, 2025 | -1.70% |
| Sep 30, 2025 | -5.19% |
| Jun 30, 2025 | -4.89% |
| Mar 31, 2025 | 5.46% |
| Dec 31, 2024 | 17.17% |
| Sep 30, 2024 | 20.99% |
| Jun 30, 2024 | 19.50% |
| Mar 31, 2024 | 13.59% |
| Dec 31, 2023 | 13.37% |
| Sep 30, 2023 | 15.87% |
| Jun 30, 2023 | 4.38% |
| Mar 31, 2023 | 7.44% |
| Dec 31, 2022 | 7.63% |
| Sep 30, 2022 | 6.65% |
| Jun 30, 2022 | 7.96% |
| Mar 31, 2022 | 1.20% |
| Dec 31, 2021 | -3.11% |
| Sep 30, 2021 | -1.39% |
| Jun 30, 2021 | 0.50% |